Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0C2QS
|
||||
Former ID |
DIB009168
|
||||
Drug Name |
MEDI-3617
|
||||
Synonyms |
Fully human anti-angiopoietin 2 mAb (cancer), MedImmune
|
||||
Drug Type |
Antibody
|
||||
Indication | Solid tumours [ICD9: 140-199, 210-229; ICD10:C00-D48] | Phase 1 | [548917] | ||
Company |
Astrazeneca; medimmune
|
||||
Target and Pathway | |||||
Target(s) | Angiopoietin-2 | Target Info | [531798] | ||
NetPath Pathway | TGF_beta_Receptor Signaling Pathway | ||||
PANTHER Pathway | Angiogenesis | ||||
Pathway Interaction Database | Angiopoietin receptor Tie2-mediated signaling | ||||
Reactome | Tie2 Signaling | ||||
WikiPathways | Cell surface interactions at the vascular wall | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.